Grunenthal GmbH - Strategic SWOT Analysis Review
November 2019
33
About the Report
About the Report
Grunenthal GmbH-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-GlobalData's summarization of the company's business strategy.
- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.
Highlights
Grunenthal GmbH (Grunenthal) is a research-oriented pharmaceutical company. It researches, develops and markets products for the treatment of pain and innovative formulations of established active substances. The company provides new chemical entities including opioids for moderate to severe pain, vanilloid receptors and KCNQ channel openers for chronic neuropathic pain; and the Bradykinin receptor for the treatment of chronic diseases with inflammation. Grunenthal also focuses on discovering new methods to treat pain, developing new medical devices, and new platform technologies for drug delivery. The company operates along with subsidiaries in Europe, Latin America and the US. Grunenthal is headquartered in Aachen, Germany.
Grunenthal GmbH Key Recent Developments
May 02,2019: Five young scientists win EFIC-Grunenthal grant 2018
Jan 22,2019: Grunenthal appoints Fabian Raschke as Chief Financial Officer (CFO)
Dec 07,2018: Research project aims to make pain visible
Oct 31,2018: AstraZeneca signs USD 922m licensing deal with Grunenthal
Jun 15,2018: Grunenthal Selected as One of the Best Employers in Europe for the Third Time
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Products
Products
Grunenthal GmbH, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.
Companies
TAD Pharma GmbH
Purdue Pharma LP
Pensa Pharma GmbH
Mundipharma International Ltd
Mibe GmbH Arzneimittel
Endo Pharmaceuticals Inc
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
Grunenthal GmbH-Key Facts
Grunenthal GmbH-Key Employees
Grunenthal GmbH-Key Employee Biographies
Grunenthal GmbH-Major Products and Services
Grunenthal GmbH-History
Grunenthal GmbH-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2-Company Analysis
Company Overview
Grunenthal GmbH-Business Description
R&D Overview
Grunenthal GmbH-Corporate Strategy
Grunenthal GmbH-SWOT Analysis
SWOT Analysis-Overview
Grunenthal GmbH-Strengths
Grunenthal GmbH-Weaknesses
Grunenthal GmbH-Opportunities
Grunenthal GmbH-Threats
Grunenthal GmbH-Key Competitors
Section 3-Company's Lifesciences Financial Deals and Alliances
Grunenthal GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Grunenthal GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Grunenthal GmbH, Recent Deals Summary
Section 4-Company's Recent Developments
May 02, 2019: Five young scientists win EFIC-Grunenthal grant 2018
Jan 22, 2019: Grunenthal appoints Fabian Raschke as Chief Financial Officer (CFO)
Dec 07, 2018: Research project aims to make pain visible
Oct 31, 2018: AstraZeneca signs USD 922m licensing deal with Grunenthal
Jun 15, 2018: Grunenthal Selected as One of the Best Employers in Europe for the Third Time
Section 5-Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Grunenthal GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Grunenthal GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
Grunenthal GmbH, Key Facts
Grunenthal GmbH, Key Employees
Grunenthal GmbH, Key Employee Biographies
Grunenthal GmbH, Major Products and Services
Grunenthal GmbH, History
Grunenthal GmbH, Other Locations
Grunenthal GmbH, Subsidiaries
Grunenthal GmbH, Key Competitors
Grunenthal GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Grunenthal GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Grunenthal GmbH, Recent Deals Summary
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.